The Antenatal Corticosteroids Trial (ACT)'s explanations for neonatal mortality - a secondary analysis.

Reprod Health · 2016 · PMC4878056 · PMID 27220987

Europe PMC DOI

hedged sentence

0.0800

closest p · 1.6× alpha

0.0800

boldest claim

The sentences

marginally significantp = 0.08so close (0.05 < p ≤ 0.1)

However, in infants with birth weight ≥25 th percentile we observed a marginally significant 15 % increase in the risk of pSBI [adjusted RR: 1.15 (0.98–1.35), p = 0.08].

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.